Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT).

MLA

Jolliffe, David A., et al. “Effect of a Test-and-Treat Approach to Vitamin D Supplementation on Risk of All Cause Acute Respiratory Tract Infection and Covid-19: Phase 3 Randomised Controlled Trial (CORONAVIT).” BMJ (Clinical Research Ed.), vol. 378, Sept. 2022, p. e071230. EBSCOhost, https://doi.org/10.1136/bmj-2022-071230.

APA

Jolliffe, D. A., Holt, H., Greenig, M., Talaei, M., Perdek, N., Pfeffer, P., Vivaldi, G., Maltby, S., Symons, J., Barlow, N. L., Normandale, A., Garcha, R., Richter, A. G., Faustini, S. E., Orton, C., Ford, D., Lyons, R. A., Davies, G. A., Kee, F., … Martineau, A. R. (2022). Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ (Clinical Research Ed.), 378, e071230. https://doi.org/10.1136/bmj-2022-071230

Chicago

Jolliffe, David A, Hayley Holt, Matthew Greenig, Mohammad Talaei, Natalia Perdek, Paul Pfeffer, Giulia Vivaldi, et al. 2022. “Effect of a Test-and-Treat Approach to Vitamin D Supplementation on Risk of All Cause Acute Respiratory Tract Infection and Covid-19: Phase 3 Randomised Controlled Trial (CORONAVIT).” BMJ (Clinical Research Ed.) 378 (September): e071230. doi:10.1136/bmj-2022-071230.